Premium
SHORT DIAGNOSIS‐TO‐TREATMENT INTERVAL IS ASSOCIATED WITH HIGH RISK AND POOR OUTCOMES IN DIFFUSE LARGE B‐CELL LYMPHOMA
Author(s) -
Casan J.,
Ansell E.,
Davies A.,
Gilbertson M.,
Opat S.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.84_2631
Subject(s) - medicine , clinical trial , diffuse large b cell lymphoma , confidence interval , proportional hazards model , hazard ratio , oncology , lymphoma